BRIEF published on 12/11/2025 at 07:05, 10 months 30 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 10 months 30 days ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
PRESS RELEASE published on 12/11/2025 at 07:00, 10 months 30 days ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 11 months 12 days ago Nouveau nombre d'actions et droits de vote d'Innate Pharma Euronext Paris Capital Social Nasdaq Innate Pharma Actions Et Droits
BRIEF published on 11/28/2025 at 07:05, 11 months 12 days ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
PRESS RELEASE published on 11/28/2025 at 07:00, 11 months 12 days ago Informations privilégiées / Autres communiqués Innate Pharma communique le nouveau nombre d'actions et de droits de vote au 27 novembre 2025 selon la réglementation en vigueur avec 92 196 523 actions ordinaires et 92 962 943 droits de vote théoriques Droits De Vote Actions AMF Innate Pharma Biotechnologies
BRIEF published on 11/17/2025 at 07:05, 11 months 23 days ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
BRIEF published on 11/17/2025 at 07:05, 11 months 23 days ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
PRESS RELEASE published on 11/17/2025 at 07:00, 11 months 23 days ago Informations privilégiées / Autres communiqués Innate Pharma présentera lors de la Jefferies Global Healthcare Conference à Londres le 17 novembre 2025. La société développe des traitements d'immunothérapies contre le cancer Société Cancer Innate Pharma Jefferies Global Healthcare Conference Immunothérapies
PRESS RELEASE published on 11/17/2025 at 07:00, 11 months 23 days ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
Published on 11/10/2026 at 21:00, 49 minutes ago Golden Minerals Announces Completion of Offering for C$5,000,000
Published on 11/10/2026 at 14:45, 7 hours 4 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 7 hours 18 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 7 hours 19 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 7 hours 19 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 19:21, 2 hours 28 minutes ago ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites
Published on 11/10/2026 at 18:54, 2 hours 55 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 3 hours 4 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:00, 3 hours 49 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 4 hours 4 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 4 hours 14 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 4 hours 18 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
